• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有和没有心力衰竭的临床显著三尖瓣反流患者的医疗保健利用。

Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failure.

机构信息

Department of Medicine, Division of Cardiology, Vanderbilt University Medical Center, Nashville, TN, USA.

Scripps Clinic, La Jolla, CA, USA.

出版信息

J Comp Eff Res. 2021 Jan;10(1):29-37. doi: 10.2217/cer-2020-0198. Epub 2020 Nov 11.

DOI:10.2217/cer-2020-0198
PMID:33174767
Abstract

This study evaluated how the presence of right-sided heart disease (RSHD), other valve disease (OVD) and heart failure (HF) impacts healthcare utilization in patients with tricuspid valve disease (tricuspid regurgitation [TR]). Of the 33,686 patients with TR: 6618 (19.6%) had TR-only; 8952 (26.6%) had TR with HF; 12,367 (36.7%) had TR with OVD but no HF; and 5749 (17.1%) had TR with RSHD only. The presence of RSHD, OVD or HF in patients with TR was independently associated with increased annualized hospitalizations, hospital days and costs relative to patients with TR alone. All three co-morbidities were associated with increased healthcare utilization, with HF showing the greatest impact across all measures.

摘要

本研究评估了右心疾病(RSHD)、其他瓣膜疾病(OVD)和心力衰竭(HF)的存在如何影响三尖瓣疾病(三尖瓣反流[TR])患者的医疗保健利用。在 33686 例 TR 患者中:6618 例(19.6%)为单纯 TR;8952 例(26.6%)为合并 HF 的 TR;12367 例(36.7%)为合并 OVD 但无 HF 的 TR;5749 例(17.1%)为单纯 RSHD 的 TR。TR 患者存在 RSHD、OVD 或 HF 与单独 TR 患者相比,年度住院次数、住院天数和费用均呈独立增加趋势。所有三种合并症均与医疗保健利用增加相关,HF 在所有指标中影响最大。

相似文献

1
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failure.有和没有心力衰竭的临床显著三尖瓣反流患者的医疗保健利用。
J Comp Eff Res. 2021 Jan;10(1):29-37. doi: 10.2217/cer-2020-0198. Epub 2020 Nov 11.
2
Comparison of Survival in Patients With Clinically Significant Tricuspid Regurgitation With and Without Heart Failure (From the Optum Integrated File).有和没有心力衰竭的具有临床显著意义三尖瓣反流患者的生存情况比较(来自Optum综合档案)
Am J Cardiol. 2021 Apr 1;144:125-130. doi: 10.1016/j.amjcard.2020.12.070. Epub 2020 Dec 30.
3
The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims database.在大型行政索赔数据库中,临床显著三尖瓣反流的经济影响。
J Med Econ. 2020 May;23(5):521-528. doi: 10.1080/13696998.2020.1718681. Epub 2020 Mar 2.
4
Functional tricuspid regurgitation and recurrent admissions in patients with acute heart failure.急性心力衰竭患者的功能性三尖瓣反流和再入院。
Int J Cardiol. 2019 Sep 15;291:83-88. doi: 10.1016/j.ijcard.2019.03.051. Epub 2019 Mar 27.
5
Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure.经导管缘对缘修复术治疗心力衰竭伴重度三尖瓣反流患者的 6 个月结局。
Eur J Heart Fail. 2018 Jun;20(6):1055-1062. doi: 10.1002/ejhf.1147. Epub 2018 Apr 26.
6
Tricuspid regurgitation in acute heart failure: is there any incremental risk?三尖瓣反流在急性心力衰竭中的作用:是否存在额外风险?
Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):993-1001. doi: 10.1093/ehjci/jex343.
7
Healthcare utilization and expenditures in patients with tricuspid regurgitation: A population-based cohort study.三尖瓣反流患者的医疗保健利用与支出:一项基于人群的队列研究。
Int J Cardiol Heart Vasc. 2024 Aug 22;54:101495. doi: 10.1016/j.ijcha.2024.101495. eCollection 2024 Oct.
8
Impact of Tricuspid Regurgitation in Patients With Heart Failure and Mitral Valve Disease from a Nationwide Cohort Study.全国队列研究中三尖瓣反流对心力衰竭合并二尖瓣疾病患者的影响。
Am J Cardiol. 2019 Sep 15;124(6):926-931. doi: 10.1016/j.amjcard.2019.05.070. Epub 2019 Jun 24.
9
Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients.经静脉心室起搏导线对小儿及先天性心脏病患者三尖瓣反流的影响。
J Interv Card Electrophysiol. 2008 Jan;21(1):65-8. doi: 10.1007/s10840-007-9183-0. Epub 2007 Nov 27.
10
Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure.经导管缘对缘三尖瓣修复术治疗重度三尖瓣反流可减少心力衰竭住院。
JACC Heart Fail. 2020 Apr;8(4):265-276. doi: 10.1016/j.jchf.2019.12.006.

引用本文的文献

1
Percutaneous interventions in tricuspid valve disease: a new era in cardiac treatment.经皮三尖瓣疾病介入治疗:心脏治疗的新时代。
Ann Med Surg (Lond). 2025 May 30;87(7):4262-4280. doi: 10.1097/MS9.0000000000003437. eCollection 2025 Jul.
2
Real-World Clinical Outcomes and Health Care Utilization in Patients With Severe Tricuspid Regurgitation.重度三尖瓣反流患者的真实世界临床结局与医疗保健利用情况
Struct Heart. 2025 Mar 27;9(5):100463. doi: 10.1016/j.shj.2025.100463. eCollection 2025 May.
3
Inequities in Access to Tricuspid Valve Treatments: The Impact of Procedure and Volume Requirements.
三尖瓣治疗可及性的不平等:手术和容量要求的影响。
JACC Adv. 2024 Oct 18;3(11):101342. doi: 10.1016/j.jacadv.2024.101342. eCollection 2024 Nov.
4
Tricuspid Regurgitation Complicating Heart Failure: A Novel Clinical Entity.三尖瓣反流并发心力衰竭:一种新型临床实体。
Rev Cardiovasc Med. 2024 Sep 18;25(9):330. doi: 10.31083/j.rcm2509330. eCollection 2024 Sep.
5
Healthcare utilization and expenditures in patients with tricuspid regurgitation: A population-based cohort study.三尖瓣反流患者的医疗保健利用与支出:一项基于人群的队列研究。
Int J Cardiol Heart Vasc. 2024 Aug 22;54:101495. doi: 10.1016/j.ijcha.2024.101495. eCollection 2024 Oct.
6
Transcatheter Tricuspid Interventions: Past, Present, and Future.经导管三尖瓣介入治疗:过去、现在与未来。
Methodist Debakey Cardiovasc J. 2023 May 16;19(3):57-66. doi: 10.14797/mdcvj.1250. eCollection 2023.